Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001104659-25-030090
Filing Date
2025-04-01
Accepted
2025-04-01 06:42:00
Documents
8

Document Format Files

Seq Description Document Type Size
1 POS AM tm2510922d4_posam.htm POS AM 385088
2 EXHIBIT 5.1 tm2510922d4_ex5-1.htm EX-5.1 20364
3 EXHIBIT 23.2 tm2510922d4_ex23-2.htm EX-23.2 1939
4 EX-FILING FEES tm2510922d4_ex-filingfees.htm EX-FILING FEES 16863
5 GRAPHIC tm2510922d1_posamsp1img001.jpg GRAPHIC 8452
6 GRAPHIC tm2510922d1_posamsp2001.jpg GRAPHIC 18872
7 GRAPHIC tm2510922d1_ex5-1img01.jpg GRAPHIC 8363
8 GRAPHIC tm2510922d1_ex5-1img02.jpg GRAPHIC 5547
  Complete submission text file 0001104659-25-030090.txt   482861
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-258145 | Film No.: 25796495
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)